Characteristics | Univariate model OR (95% CI) | P-Value | Multivariate model 1 OR (95% CI) | P-Value | Multivariate model 2 OR (95% CI) | P-Value |
---|---|---|---|---|---|---|
Age | 1.06 (1.03–1.09) | < 0.001 | 1.03 (1.01–1.06) | 0.03 | ||
Gender, Male | 0.83 (0.48–1.46) | 0.53 | ||||
Ethnicity, Caucasian | 1.38 (0.59–3.20) | 0.45 | ||||
Care home resident | 3.48 (1.57–6.47) | < 0.001 | 1.12 (0.52–2.40) | 0.77 | ||
Frailty | 8.71 (4.56–16.6) | < 0.001 | 5.1 (2.3–11.60) | < 0.001 | ||
Smoking | 1.75 (0.99–3.05) | 0.05 | 1.57 (0.81–3.01) | 0.18 | ||
Weight | 0.96 (0.95–0.98) | < 0.001 | ||||
BMI | 0.90 (0.86–0.95) | < 0.001 | ||||
Hypertension | 1.60 (0.95–2.87) | 0.07 | ||||
Diabetes mellitus | 0.76 (0.41–1.38) | 0.36 | ||||
CVD | 2.77 (1.58–4.88) | < 0.001 | 1.20 (0.61–2.40) | 0.59 | ||
IHD/MI | 1.47 (0.79–2.76) | 0.22 | ||||
CCF | 2.94 (1.43–6.02) | 0.003 | ||||
CVA | 3.04 (1.36–6.77) | 0.006 | ||||
CKD (stage 3–5) | 1.15 (0.58–2.29) | 0.67 | ||||
Cancer | 0.67 (0.24–1.83) | 0.44 | ||||
Respiratory diseases | 1.88 (1.05–3.40) | 0.035 | 1.51 (0.75–3.06) | 0.24 | ||
On RASi treatment | 0.61 (0.32–1.17) | 0.14 | ||||
Immunosuppression | 1.50 (0.48–4.90) | 0.47 | ||||
Haemoglobin | 0.99 (0.97–1.00) | 0.16 | ||||
Neutrophil count | 1.08 (1.01–1.14) | 0.02 | 0.95 (0.85–1.04) | 0.28 | ||
Lymphocyte count | 0.59 (0.36–0.98) | 0.04 | 1.19 (0.66–2.10) | 0.55 | ||
Neutrophil: lymphocyte ratio | 1.05 (1.01–1.08) | 0.002 | 1.05 (0.99–1.11) | 0.06 | ||
Platelet count | 0.99 (0.96–1.00) | 0.31 | ||||
Albumin | 1.00 (0.98–1.02) | 0.99 | ||||
Bilirubin | 1.01 (0.98–1.04) | 0.44 | ||||
Alanine transaminase | 1.00 (0.99–1.00) | 0.45 | ||||
Alkaline phosphatase | 1.01 (0.99–1.01) | 0.27 | ||||
C-reactive protein | 1.01 (1.0–1.010) | 0.010 | 1.0 (0.99–1.00) | 0.26 | ||
eGFR | 0.97 (0.96–0.98) | < 0.001 | 0.98 (0.96–0.99) | 0.01 | ||
Acute kidney injury | 3.60 (1.96–6.65) | < 0.001 | 1.78 (0.80–3.99) | 0.16 |